Annual EBITDA:
-$351.67M+$75.76M(+17.72%)Summary
- As of today, IOVA annual EBITDA is -$351.67 million, with the most recent change of +$75.76 million (+17.72%) on December 31, 2024.
- During the last 3 years, IOVA annual EBITDA has fallen by -$22.95 million (-6.98%).
- IOVA annual EBITDA is now -2442066.67% below its all-time high of -$14.40 thousand, reached on December 31, 2009.
Performance
IOVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$101.84M+$8.32M(+7.55%)Summary
- As of today, IOVA quarterly EBITDA is -$101.84 million, with the most recent change of +$8.32 million (+7.55%) on June 30, 2025.
- Over the past year, IOVA quarterly EBITDA has dropped by -$10.79 million (-11.85%).
- IOVA quarterly EBITDA is now -2111.26% below its all-time high of $5.06 million, reached on December 31, 2012.
Performance
IOVA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$364.80M-$10.79M(-3.05%)Summary
- As of today, IOVA TTM EBITDA is -$364.80 million, with the most recent change of -$10.79 million (-3.05%) on June 30, 2025.
- Over the past year, IOVA TTM EBITDA has increased by +$54.09 million (+12.91%).
- IOVA TTM EBITDA is now -9002.12% below its all-time high of $4.10 million, reached on March 31, 2013.
Performance
IOVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IOVA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +17.7% | -11.8% | +12.9% |
| 3Y3 Years | -7.0% | -7.8% | -1.8% |
| 5Y5 Years | -76.9% | -60.7% | -45.7% |
IOVA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -7.0% | +17.7% | -36.0% | +8.7% | -3.7% | +15.2% |
| 5Y | 5-Year | -76.9% | +17.7% | -73.6% | +8.7% | -45.7% | +15.2% |
| All-Time | All-Time | >-9999.0% | +17.7% | -2111.3% | +8.7% | -9002.1% | +15.2% |
IOVA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$101.84M(+7.6%) | -$364.80M(-3.0%) |
| Mar 2025 | - | -$110.16M(-47.1%) | -$354.01M(-0.7%) |
| Dec 2024 | -$351.67M(+17.7%) | -$74.89M(+3.9%) | -$351.67M(+9.4%) |
| Sep 2024 | - | -$77.92M(+14.4%) | -$388.33M(+7.3%) |
| Jun 2024 | - | -$91.05M(+15.5%) | -$418.89M(+2.6%) |
| Mar 2024 | - | -$107.81M(+3.3%) | -$430.09M(-0.6%) |
| Dec 2023 | -$427.43M(-13.2%) | -$111.54M(-2.8%) | -$427.43M(-2.4%) |
| Sep 2023 | - | -$108.49M(-6.1%) | -$417.22M(-3.3%) |
| Jun 2023 | - | -$102.25M(+2.8%) | -$403.93M(-2.0%) |
| Mar 2023 | - | -$105.16M(-3.8%) | -$396.17M(-4.9%) |
| Dec 2022 | -$377.74M(-14.9%) | -$101.33M(-6.4%) | -$377.74M(-1.7%) |
| Sep 2022 | - | -$95.19M(-0.7%) | -$371.42M(-3.6%) |
| Jun 2022 | - | -$94.49M(-8.9%) | -$358.50M(-4.6%) |
| Mar 2022 | - | -$86.73M(+8.7%) | -$342.66M(-4.2%) |
| Dec 2021 | -$328.72M(-29.8%) | -$95.00M(-15.5%) | -$328.72M(-11.7%) |
| Sep 2021 | - | -$82.28M(-4.6%) | -$294.36M(-8.7%) |
| Jun 2021 | - | -$78.65M(-8.0%) | -$270.75M(-6.0%) |
| Mar 2021 | - | -$72.80M(-20.0%) | -$255.46M(-0.9%) |
| Dec 2020 | -$253.22M(-27.4%) | -$60.64M(-3.4%) | -$253.22M(-1.1%) |
| Sep 2020 | - | -$58.66M(+7.4%) | -$250.45M(-3.0%) |
| Jun 2020 | - | -$63.37M(+10.2%) | -$243.08M(-5.9%) |
| Mar 2020 | - | -$70.56M(-21.9%) | -$229.59M(-15.5%) |
| Dec 2019 | -$198.75M(-56.1%) | -$57.86M(-12.8%) | -$198.75M(-13.2%) |
| Sep 2019 | - | -$51.30M(-2.8%) | -$175.58M(-10.4%) |
| Jun 2019 | - | -$49.88M(-25.6%) | -$159.09M(-13.3%) |
| Mar 2019 | - | -$39.72M(-14.5%) | -$140.37M(-10.3%) |
| Dec 2018 | -$127.30M(-38.5%) | -$34.69M(+0.3%) | -$127.30M(-7.5%) |
| Sep 2018 | - | -$34.81M(-11.7%) | -$118.44M(-12.0%) |
| Jun 2018 | - | -$31.15M(-16.9%) | -$105.73M(-8.0%) |
| Mar 2018 | - | -$26.65M(-3.2%) | -$97.91M(-6.5%) |
| Dec 2017 | -$91.92M(-74.6%) | -$25.83M(-16.9%) | -$91.92M(-12.5%) |
| Sep 2017 | - | -$22.10M(+5.3%) | -$81.73M(-4.2%) |
| Jun 2017 | - | -$23.34M(-13.0%) | -$78.46M(-17.8%) |
| Mar 2017 | - | -$20.66M(-32.2%) | -$66.58M(-26.4%) |
| Dec 2016 | -$52.66M | -$15.63M(+17.0%) | -$52.66M(-16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$18.83M(-64.4%) | -$45.20M(-33.9%) |
| Jun 2016 | - | -$11.46M(-69.9%) | -$33.74M(-18.4%) |
| Mar 2016 | - | -$6.74M(+17.5%) | -$28.49M(-6.1%) |
| Dec 2015 | -$26.86M(-124.7%) | -$8.17M(-10.8%) | -$26.86M(-14.3%) |
| Sep 2015 | - | -$7.38M(-19.0%) | -$23.49M(-24.2%) |
| Jun 2015 | - | -$6.20M(-21.3%) | -$18.91M(-27.6%) |
| Mar 2015 | - | -$5.11M(-6.5%) | -$14.82M(-24.0%) |
| Dec 2014 | -$11.95M(+47.2%) | -$4.80M(-71.7%) | -$11.95M(+35.9%) |
| Sep 2014 | - | -$2.80M(-32.7%) | -$18.65M(+26.2%) |
| Jun 2014 | - | -$2.11M(+6.0%) | -$25.25M(+4.6%) |
| Mar 2014 | - | -$2.24M(+80.5%) | -$26.47M(-6.2%) |
| Dec 2013 | -$22.63M(-2467.7%) | -$11.50M(-22.2%) | -$24.93M(-197.8%) |
| Sep 2013 | - | -$9.41M(-183.0%) | -$8.37M(-1805.2%) |
| Jun 2013 | - | -$3.32M(-372.8%) | $490.90K(-88.0%) |
| Mar 2013 | - | -$703.00K(-113.9%) | $4.10M(+564.7%) |
| Dec 2012 | -$881.50K(+95.7%) | $5.06M(+1028.4%) | -$881.80K(+90.4%) |
| Sep 2012 | - | -$545.40K(-292.7%) | -$9.18M(+36.3%) |
| Jun 2012 | - | $283.00K(+105.0%) | -$14.40M(+42.9%) |
| Mar 2012 | - | -$5.68M(-75.8%) | -$25.22M(-25.0%) |
| Dec 2011 | -$20.54M(-2614.0%) | -$3.23M(+44.0%) | -$20.18M(-16.1%) |
| Sep 2011 | - | -$5.77M(+45.3%) | -$17.39M(-47.5%) |
| Jun 2011 | - | -$10.54M(-1547.0%) | -$11.79M(-786.7%) |
| Mar 2011 | - | -$640.10K(-45.5%) | -$1.33M(-75.6%) |
| Dec 2010 | -$756.80K(-5155.6%) | -$440.00K(-167.2%) | -$757.00K(-137.3%) |
| Sep 2010 | - | -$164.70K(-94.7%) | -$319.00K(-102.7%) |
| Jun 2010 | - | -$84.60K(-25.0%) | -$157.40K(-107.7%) |
| Mar 2010 | - | -$67.70K(-3285.0%) | -$75.80K(-426.4%) |
| Dec 2009 | -$14.40K(+74.2%) | -$2000.00(+35.5%) | -$14.40K(+45.5%) |
| Sep 2009 | - | -$3100.00(-3.3%) | -$26.40K(-3.9%) |
| Jun 2009 | - | -$3000.00(+52.4%) | -$25.40K(+31.5%) |
| Mar 2009 | - | -$6300.00(+55.0%) | -$37.10K(+33.5%) |
| Dec 2008 | -$55.80K | -$14.00K(-566.7%) | -$55.80K(-33.5%) |
| Sep 2008 | - | -$2100.00(+85.7%) | -$41.80K(-5.3%) |
| Jun 2008 | - | -$14.70K(+41.2%) | -$39.70K(-58.8%) |
| Mar 2008 | - | -$25.00K | -$25.00K |
FAQ
- What is Iovance Biotherapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. annual EBITDA year-on-year change?
- What is Iovance Biotherapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Iovance Biotherapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. TTM EBITDA year-on-year change?
What is Iovance Biotherapeutics, Inc. annual EBITDA?
The current annual EBITDA of IOVA is -$351.67M
What is the all-time high annual EBITDA for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high annual EBITDA is -$14.40K
What is Iovance Biotherapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, IOVA annual EBITDA has changed by +$75.76M (+17.72%)
What is Iovance Biotherapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of IOVA is -$101.84M
What is the all-time high quarterly EBITDA for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high quarterly EBITDA is $5.06M
What is Iovance Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, IOVA quarterly EBITDA has changed by -$10.79M (-11.85%)
What is Iovance Biotherapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of IOVA is -$364.80M
What is the all-time high TTM EBITDA for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high TTM EBITDA is $4.10M
What is Iovance Biotherapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, IOVA TTM EBITDA has changed by +$54.09M (+12.91%)